Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and
Ko Yamamoto1, Hiroki Shiomi2, Takeshi Morimoto3
1Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
Insights
Patients with diabetes undergoing complex multivessel percutaneous coronary intervention (PCI) guided by intravascular ultrasound (IVUS) have similar 1-year outcomes to those without diabetes. This study highlights comparable results for this high-risk group when managed with optimal stent expansion criteria.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Data on clinical outcomes for diabetic patients undergoing intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) for multivessel disease is scarce.
- Optimal stent expansion is crucial for successful PCI outcomes, particularly in complex cases.
Purpose of the Study:
- To compare 1-year clinical outcomes between diabetic and non-diabetic patients who underwent multivessel PCI guided by IVUS.
- To assess the impact of diabetes on outcomes in patients treated with IVUS-guided PCI aiming for optimal stent expansion.
Main Methods:
- Prospective, multicenter, single-arm trial (Optimal Intravascular Ultrasound Guided Complex Percutaneous Coronary Intervention study).
- 1,021 patients with multivessel disease underwent IVUS-guided PCI, including the left anterior descending artery.
- Patients were stratified into diabetic (n=560) and non-diabetic (n=461) groups, with outcomes compared based on the prespecified OPTIVUS criteria.
Main Results:
- The rate of achieving optimal stent expansion (OPTIVUS criteria) was similar between diabetic and non-diabetic groups (61.2% vs. 60.7%, p=0.83).
- Diabetic patients had more complex coronary artery disease, evidenced by higher stent utilization and longer stent lengths.
- The primary endpoint (composite of death, myocardial infarction, stroke, or revascularization) at 1 year was comparable: 10.8% in diabetics vs. 9.8% in non-diabetics (log-rank p=0.65).
- Adjusted analysis showed no significant difference in the primary endpoint risk between groups (HR 0.97, 95% CI 0.65-1.44, p=0.88).
Conclusions:
- In patients undergoing multivessel IVUS-guided PCI with contemporary management, diabetes does not appear to be associated with significantly different 1-year clinical outcomes.
- Achieving optimal stent expansion with IVUS is feasible and yields similar results in both diabetic and non-diabetic patients with multivessel disease.
- These findings suggest that IVUS-guided PCI can effectively manage complex multivessel disease in diabetic patients, leading to comparable outcomes to their non-diabetic counterparts.
Abstract:
There is a scarcity of data on clinical outcomes after intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with multivessel disease and diabetes. The Optimal Intravascular Ultrasound Guided Complex Percutaneous Coronary Intervention study multivessel cohort was a prospective, multicenter, single-arm trial enrolling 1,021 patients who underwent multivessel PCI, including left anterior descending coronary artery using IVUS, aiming to meet the prespecified OPTIVUS criteria for optimal stent expansion. We compared the clinical outcomes between those patients with and without diabetes. The primary end point was a composite of death, myocardial infarction, stroke, or any coronary revascularization. There were 560 patients (54.8%) with diabetes and 461 patients (45.2%) without diabetes. The mean age was not different between the 2 groups (70.9 ± 9.7 vs 71.7 ± 10.4 years, p = 0.17). Patients with diabetes more often had chronic kidney disease and complex coronary artery disease, as indicated by the greater total number of stents and longer total stent length. The rate of meeting the OPTIVUS criteria was not different between the 2 groups (61.2% vs 60.7%, p = 0.83). The cumulative 1-year incidence of the primary end point was not different between the 2 groups (10.8% vs 9.8%, log-rank p = 0.65). After adjusting for confounders, the risk of diabetes relative to nondiabetes remained insignificant for the primary end point (hazard ratio 0.97, 95% confidence interval 0.65 to 1.44, p = 0.88). In conclusion, in patients who underwent multivessel IVUS-guided PCI and were managed with contemporary clinical practice, patients with diabetes had similar 1-year outcomes to patients without diabetes.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Complications of Diabetes Mellitus
Diabetic Foot Ulcer
Diabetic Retinopathy
